Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Inflection Biosciences
Dublin pharma development company’s drug blocks pathways used by cancer cells
Inflection Biosciences working on new way to block spread of cancer cells in patients
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Start-up working on way to block spread of cancer cells in patients with aggressive breast cancer
Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices